Overview

Pregabalin in the Prevention of Postoperative Delirium and Pain

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether administration of pregabalin by mouth immediately preoperatively and three times daily for 3 days after surgery reduces the incidence of delirium postoperatively and improves overall pain control.
Phase:
Phase 3
Details
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborator:
Pfizer
Treatments:
Pregabalin